digest
Short Summary
Main recommendation: Huberman highlights GLP-1 (glucagon-like peptide 1) as a peptide that suppresses appetite through two parallel pathways, and he presents yerba mate as a mild, food-sourced way to stimulate its release. He also notes that newer prescription drugs that stimulate GLP-1 or are synthetic GLP-1 are showing strong results for diabetes and obesity. The key idea is that these effects operate via parallel gut and brain mechanisms.
Key Points
- GLP-1 (glucagon-like peptide 1) is a small protein (peptide) that can dramatically suppress appetite, which is why GLP-1 drugs are being studied for type 2 diabetes and obesity weight loss.
- The cited Cell paper, "An inter-organ neural circuit for appetite suppression," describes two parallel pathways: GLP-1 acts on gut neurons and on the brain.
- In the gut, GLP-1 binds to intestinofugal enteric neurons in the enteric nervous system, causing gut distension that creates a feeling of fullness.
- In the brain, signals travel from the gut to the hypothalamus, which triggers satiety (the feeling of having had enough food).
- Parallel pathways are presented as a general organizing principle of biology, with examples such as parallel epinephrine/adrenaline activation during arousal.
Details Worth Noting
- Concrete instructions: The transcript gives no dosing, timing, frequency, or preparation steps for yerba mate or GLP-1 drugs. The only actionable advice is to choose non-smoked yerba mate and avoid the smoky-flavored varieties because of concerns about possible carcinogenic effects. Huberman says that for those seeking mild appetite suppression with caffeine, yerba mate may be an option, but he does not specify amounts or how to prepare it.
- Huberman states that yerba mate's GLP-1 release is much lower than that from GLP-1 drugs, and that appropriately dosed synthetic GLP-1 or drugs should cause mild rather than major gut distension, since major distension would be uncomfortable.
- He personally uses yerba mate as a preferred caffeine source for early-day focus, work, and exercise, and avoids smoked varieties.
- He notes the publication's journal, Cell, is one of the three "apex" journals alongside Nature and Science.
- The discussion of parallel pathways extends beyond appetite to general biology, with brain-body communication described as usually bidirectional.
Bottom Line
Appetite suppression via GLP-1 works through both gut and brain signaling, and the same parallel-pathway logic appears throughout biology. For practical use, Huberman frames yerba mate as a milder option than GLP-1 drugs and recommends avoiding smoked varieties.
